Extended Conjugation Refining Carbon Nitride for Non-sacrificial H2O2 Photosynthesis and Hypoxic Tumor Therapy

25 July 2022, Version 2
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

Artificial photocatalysis offers a clean approach for producing H2O2. However, the poor selectivity and activity of H2O2 production hamper traditional industrial applications and emerging photodynamic therapy (PDT)/chemodynamic therapy (CDT). Here, we report a well-defined C5N2 photocatalyst with a conjugated C=N linkage for highly selective and efficient non-sacrificial H2O2 production both in normoxic and hypoxic systems. The strengthened delocalization of π-electrons by linkers in C5N2 significantly downshifted the band position, which eliminated the side photoreduction reaction of H2 evolution in thermodynamics and promoted water oxidation ability in kinetics. As a result, C5N2 had a competitive overall H2O2 production with solar-to-chemical conversion efficiency of 0.55% and more interestingly, exhibited the highest activity so far in hypoxic condition (698 μM/h). C5N2 was further applied to hypoxic PDT/CDT, exhibiting outstanding performance in conspicuous cancer cell death and synchronous bioimaging. It shed light on unlocking linker functions in electronic structure engineering of carbon nitrides for highly efficient overall photosynthesis of H2O2 and expanded the scope of their prospective application in health care.

Keywords

photocatalysts
carbon nitrides
hydrogen peroxide
non-sacrificial
photodynamic therapy
hypoxic tumor
electron delocalization

Supplementary materials

Title
Description
Actions
Title
Supporting information
Description
Experimental details, additional figures, tables, and references.
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.